Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective studyHouli Zhao, Yongxian Hu, Jimin Shi et al.|Journal of Hematology & Oncology|2020Cited by 82
Targeted tilianin lipid nanoparticles for the treatment of atherosclerosis through remodeling lesional macrophage phenotypeYaoyao Luo, Xiangrong Song, Zhongshan He et al.|Nano Research|2024Cited by 2